A series of transcription factors including the immediate-early genes, such as c-fos and c-jun, which are components of AP-1, and its downstream target genes including atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP) have been implicated in the development of cardiac hypertrophy. The gene discussed is NPPA; the disease is cardiac hypertrophy.